AbstractObjective To explore the change in anatomical volume during intensity-modulated radiotherapy (IMRT) for different stages of nasopharyngeal carcinoma (NPC) and its influence on dose distribution, and to assess the necessity to modify the IMRT plan. Methods Twenty-four patients with newly diagnosed NPC who received IMRT and chemotherapy were enrolled in the study, and were divided into early-intermediate group (12 cases) and locally advanced group (12 cases) according to the 2008 staging system for NPC. Each patient had a repeated CT scan at week 5 of radiotherapy, and target volume and organs at risk (OAR) were contoured. The dose distribution of the original plan shown on CT was calculated. Changes in target volume, OAR anatomical volume, and dose distribution were analyzed, and paired t-test and Spearman correlation analysis were performed. Results In the early-intermediate group, gross target volume of neck positive lymph nodes (GTVnd) was reduced during radiotherapy (P=0.059), and gross target volume of nasopharynx (GTVnx), high-risk clinical target volume (CTV1), and parotid volume were reduced significantly during radiotherapy (P=0.001, 0.012, 0.002, and 0.000, respectively). In locally advanced group, GTVnx, GTVnd, CTV1, and parotid volume were significantly reduced during IMRT (P=0.000, 0.000, 0.003, 0.003, and 0.000, respectively). Compared with the values before radiotherapy, the parotid dose increased significantly in the two groups during IMRT (P=0.044, 0.026, 0.033, and 0.026, respectively;P=0.024, 0.016, 0.030, and 0.015, respectively), and the increase in GTVnd dose was observed in the locally advanced group (P=0.029 and 0.049). Conclusions It is recommended to perform another CT scan for patients with locally advanced NPC at week 5 of radiotherapy and formulate a new IMRT plan to maintain target volume dose and guarantee a safe parotid dose.
Hu Xuefeng,Liu Guichao,Lin Li et al. Influence of change in anatomical volume on dose distribution during intensity-modulated radiotherapy for different stages of nasopharyngeal carcinoma[J]. Chinese Journal of Radiation Oncology, 2015, 24(6): 664-667.
Hu Xuefeng,Liu Guichao,Lin Li et al. Influence of change in anatomical volume on dose distribution during intensity-modulated radiotherapy for different stages of nasopharyngeal carcinoma[J]. Chinese Journal of Radiation Oncology, 2015, 24(6): 664-667.
[1] Cheng HC,Wu VW,Ngan RK,et al. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients[J].Radiother Oncol,2012,104(3):317-323.DOI:10.1016/j.radonc.2012.03.013. [2] 曹建忠,罗京伟,徐国镇,等.鼻咽癌调强放疗中解剖及剂量学改变再次计划必要性研究[J].中华放射肿瘤学杂志,2008,17(3):161-164.DOI:10.3321/j.issn:1004-4221.2008.03.001. [3] Wang RH,Zhang SX,Zhou LH,et al. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma[J].Biomed Mater Eng,2014,24(1):1217-1225.DOI:10.3233/BME-130923. [4] Zhang X,Li M,Cao J,et al. Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy[J].Br J Radiol,2012,85(1016):506-513.DOI:10.1259/bjr/20695672. [5] 中国鼻咽癌临床分期工作委员会.2010鼻咽癌调强放疗靶区及剂量设计指引专家共识[J].中华放射肿瘤学杂志,2011,20(4):267-269.DOI:10.3760/cma.j.issn.1004-4221.2011.04.001. [6] Wong FCS,Ng AWY,Lee VHF,et al. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patient s with nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,2010,76(1):138-145.DOI:10.1016/j.ijrobp.2009.01.084. [7] 黄劭敏,邓小武,赵充,等.鼻咽癌调强放疗中解剖结构改变对剂量分布影响研究[J].中华放射肿瘤学杂志,2010,19(5):404-408.DOI:10.3760/cma.j.issn.1004-4221.2010.05.005. [8] Barker JL,Garden AS,Ang KK,et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system[J].Int J Radiat Oncol Biol Phys,2004,59(4):960-970.DOI:10.1016/j.ijrobp.2003.12.024. [9] Lu J,Ma YD,Chen JH,et al. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma[J].J Radiat Res,2014,55(1):97-104.DOI:10.1093/jrr/rrt076.
2015, Vol. 24 
